Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
03/2014
03/27/2014WO2014047111A1 Sgc stimulators
03/27/2014WO2014047024A1 Iap antagonists
03/27/2014WO2014045292A1 Improved process for the preparation of linezolid intermediate
03/27/2014WO2014044757A1 Cationic triphenylamine derivatives activable by visible and infra red light for inducing and imaging apoptosis in cancer cells
03/27/2014WO2014044738A1 Benzoimidazole-carboxylic acid amide derivatives as apj receptor modulators
03/27/2014WO2014044107A1 Pyrazol[3,4-c] pyridine derivative, preparation method and use in medicine thereof
03/27/2014US20140088094 N-SULFONYLATED TETRAHYDROQUINOLINES AND RELATED BICYCLIC COMPOUNDS FOR INHIBITION OF RORgamma ACTIVITY AND THE TREATMENT OF DISEASE
03/27/2014US20140088084 Oxazine derivatives and their use in the treatment of neurological disorders
03/27/2014US20140088082 Inhibitors of the plasmodial surface anion channel as antimalarials
03/27/2014US20140088079 Novel diphenylmethane derivatives as sglt2 inhibitors
03/27/2014US20140088076 Substituted 6,6-fused nitrogenous heterocyclic compounds and uses thereof
03/27/2014US20140088071 sGC STIMULATORS
03/26/2014EP2711366A1 Cationic triphenylamine derivatives activable by visible and Infra Red light for inducing and imaging apoptosis in cancer cells
03/26/2014EP2710002A1 Polymorph form of 4-{[4-({[4-(2,2,2-trifluoroethoxy)-1,2-benzisoxazol-3-yl]oxy}methyl)piperidin-1-yl]methyl}-tetrahydro-2h-pyran-4-carboxylic acid
03/26/2014EP2710001A1 Process for obtaining rivaroxaban and intermediate thereof
03/26/2014EP2710000A1 Parasiticidal dihydroisoxazole compounds
03/26/2014EP2709997A1 Inhibitors of bruton's tyrosine kinase
03/26/2014EP2709992A1 1,3-oxazines as bace1 and/or bace2 inhibitors
03/26/2014CN103687857A Cytosolic fluorescent ion indicators
03/26/2014CN103687855A Imidazole derivatives
03/26/2014CN103664923A Preparation method for nifuratel
03/26/2014CN103664922A Novel crystal-form azilsartan and preparation method for same
03/26/2014CN103664921A Azilsartan of crystal form A, and preparation method thereof
03/26/2014CN103664920A Preparation method of azilsartan intermediate and azilsartan
03/26/2014CN103664919A Compound used for preparing chemotherapeutical medicines
03/26/2014CN103664918A Tetralin isobenzazole-1,3-diketone substituent benzoxazolinone derivative
03/26/2014CN103664917A Synthesis method for 2-substituent oxazoline or 2-substituent oxazine
03/26/2014CN103664908A Aminopyrimidine heterocyclic compound having adenosine receptor antagonizing activity
03/26/2014CN103664899A Heteroaryl-substituted dihydropyrimidine compounds and application thereof in medicines
03/26/2014CN103664802A Quinazoline analogs as receptor tyrosine kinase inhibitors
03/26/2014CN103664793A Azilsartan intermediate and preparation method thereof
03/26/2014CN103664792A Azilsartan intermediate and preparation method thereof
03/26/2014CN103664749A Condensed-cyclic compound and organic light-emitting diode including the condensed-cyclic compound
03/26/2014CN103657724A Keggin type vacancy polyacid and application thereof in catalytic synthesis of benzoxazole derivative
03/26/2014CN102285977B 5-tert-butyl-3-aryl-4-(1,2,4-triazol-1-yl)isoxazolidin-5-ol and application thereof
03/26/2014CN102229604B Preparation and synthetic method for chiral oxazoline
03/26/2014CN102190656B Oxazolidinone bacteriophage containing azaheterocycle
03/26/2014CN101918372B Process for preparing N-substituted hydroxypyrimidinone carboxamides
03/26/2014CN101715442B Heterocyclic aspartyl protease inhibitors
03/26/2014CN101426766B Novel heteroaryl-substituted arylaminopyridine derivatives as MEK inhibitors
03/25/2014US8680269 Pesticidal compositions
03/25/2014US8680268 Sulfonic acid derivative compound and novel naphthalic acid derivative compound
03/25/2014US8680119 Ethers, secondary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
03/25/2014US8680118 Therapeutic agents useful for treating pain
03/25/2014US8680115 Tetrahydroquinoline analogues as muscarinic agonists
03/25/2014US8680097 Benzothiophene alkanol piperazine derivatives and their use as antidepressant
03/25/2014US8680093 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
03/25/2014US8680092 Nitrogenous heterocyclic compound and medicinal use thereof
03/25/2014US8680090 Sulfonyl containing benzothiazole inhibitors of endothelial lipase
03/25/2014US8679773 Kits pertaining to analyte determination
03/25/2014CA2699989C N-phenyl-dioxo-hydro pyrimidines useful as hepatitis c virus (hcv) inhibitor
03/25/2014CA2623879C Sulfonamide derivatives and use thereof for the modulation of metalloproteinases
03/25/2014CA2620688C Heterocyclic compound
03/25/2014CA2617099C Macrocyclic inhibitors of hepatitis c virus
03/25/2014CA2606783C Modulators of indoleamine 2,3-dioxygenase and methods of using the same
03/25/2014CA2594418C N-(heteroaryl)-1h-indole-2-carb0xamide derivatives and their use as vanilloid trpv1 receptor ligands
03/20/2014WO2014043019A1 Hiv protease inhibitors
03/20/2014WO2014042263A1 Novel renin inhibitor
03/20/2014WO2014042238A1 Sulfonamide compound
03/20/2014WO2014041106A1 Triazole carboxamide derivatives
03/20/2014WO2014041007A1 Pyrazole carboxamide derivatives as taar modulators for use in the treatment of several disorders, such as depression, diabetes and parkinson's disease
03/20/2014WO2014040965A1 Inhibitors of bruton's tyrosine kinase
03/20/2014WO2014040938A1 Non-annulated thiophenylamides as inhibitors of fatty acid binding proteini(fabp) 4 and/or 5
03/20/2014WO2014012050A3 Compounds for treatment of spinal muscular atrophy
03/20/2014WO2014009969A3 Novel polymorphs of azilsartan
03/20/2014WO2013151719A3 Fluorinated oxazolidinone derivatives
03/20/2014US20140081025 Heteroaromatic ring derivative
03/20/2014US20140080872 Use of phospho-akt as a biomarker of drug response
03/20/2014US20140080835 Quinazolinone derivatives as parp inhibitors
03/20/2014US20140080830 Novel Compounds
03/20/2014US20140080829 Pyrimidyl cyclopentanes as akt protein kinase inhibitors
03/20/2014US20140080828 Imidazolyl amide compounds and uses related thereto
03/20/2014US20140080827 Novel kinase modulators
03/20/2014US20140080825 Modulators of ATP-binding cassette transporters
03/20/2014US20140080819 Halogen-alkyl-1,3 oxazines as bace1 and/or bace2 inhibitors
03/20/2014US20140080810 Benzoxazepines as Inhibitors of PI3K/mTOR and Methods of Their Use and Manufacture
03/20/2014US20140080788 Novel bicyclic nitrogen containing heteroaryl tgr5 receptor modulators
03/20/2014US20140080168 Class of near infrared optical probes for biological applications
03/20/2014US20140079736 Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria
03/20/2014US20140076726 Detection of Immobilized Nucleic Acid
03/19/2014EP2707372A2 Spiro-oxindole mdm2 antagonists
03/19/2014EP2707365A1 Hepatitis c virus inhibitors
03/19/2014EP2707361A1 Fused heterocyclic compounds as sodium channel modulators
03/19/2014EP2707358A1 Benzazepine derivatives, pharmaceutical compositions containing them, and their use in therapy
03/19/2014EP2707026A1 Production of dense bodies (db) from hcmv-infected cells
03/19/2014CN103649079A Hepatitis C inhibitors and uses thereof
03/19/2014CN103649077A Sulphonamide derivatives of alicyclic amines for the treatment of central nervous system diseases
03/19/2014CN103649076A Pyrrolidinyl urea and pyrrolidinyl thiourea compounds as trka kinase inhibitors
03/19/2014CN103649074A Substituted azaheterocycles for the treatment of cancer
03/19/2014CN103649059A 5-membered ring aromatic heterocyclic derivative having NPY Y5 receptor antagonistic activity
03/19/2014CN103649056A Fused heterocyclic compounds as sodium channel modulators
03/19/2014CN103649053A Aminomethyl quinolone compounds
03/19/2014CN103649048A Indoleamine derivatives for the treatment of central nervous system diseases
03/19/2014CN103642487A Fluorescence probe based on 1, 3, 4-oxadiazole derivative, and synthetic method and applications thereof
03/19/2014CN103641825A Naphthalimide derivative and application thereof as enzyme inhibitor and pesticide
03/19/2014CN103641816A Compounds and compositions as protein kinase inhibitors
03/19/2014CN101754965B CSF-1R inhibitors, compositions, and methods of use
03/18/2014US8674113 Compounds
03/18/2014US8674111 Oxazole and thiazole derivatives as ALX receptor agonists
03/18/2014US8674106 Alkynyl derivatives as modulators of metabotropic glutamate receptors
1 ... 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 ... 647